Qinlei Zheng, Ph.D. - Publications
Affiliations: | 2006 | University of Rochester, Rochester, NY |
Area:
PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Zhao S, Guo J, Zhao Y, Fei C, Zheng Q, Li X, Chang C. Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling. American Journal of Translational Research. 8: 3169-78. PMID 27508038 | 0.31 | |||
2005 | Tai LK, Zheng Q, Pan S, Jin ZG, Berk BC. Flow activates ERK1/2 and endothelial nitric oxide synthase via a pathway involving PECAM1, SHP2, and Tie2. The Journal of Biological Chemistry. 280: 29620-4. PMID 15985432 DOI: 10.1074/Jbc.M501243200 | 0.491 | |||
2005 | Yin G, Zheng Q, Yan C, Berk BC. GIT1 is a scaffold for ERK1/2 activation in focal adhesions. The Journal of Biological Chemistry. 280: 27705-12. PMID 15923189 DOI: 10.1074/Jbc.M502271200 | 0.612 | |||
2005 | Pi X, Garin G, Xie L, Zheng Q, Wei H, Abe J, Yan C, Berk BC. BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha. Circulation Research. 96: 1145-51. PMID 15879308 DOI: 10.1161/01.Res.0000168802.43528.E1 | 0.596 | |||
2004 | Zheng Q, Yin G, Yan C, Cavet M, Berk BC. 14-3-3beta binds to big mitogen-activated protein kinase 1 (BMK1/ERK5) and regulates BMK1 function. The Journal of Biological Chemistry. 279: 8787-91. PMID 14679215 DOI: 10.1074/Jbc.M310212200 | 0.573 | |||
Show low-probability matches. |